BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29047390)

  • 1. Roles of BCCIP deficiency in mammary tumorigenesis.
    Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
    Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
    Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
    Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCCIP suppresses tumor initiation but is required for tumor progression.
    Huang YY; Dai L; Gaines D; Droz-Rosario R; Lu H; Liu J; Shen Z
    Cancer Res; 2013 Dec; 73(23):7122-33. PubMed ID: 24145349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1.
    Meng X; Lu H; Shen Z
    Cell Cycle; 2004 Nov; 3(11):1457-62. PubMed ID: 15539944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential roles of BCCIP in mouse embryonic development and structural stability of chromosomes.
    Lu H; Huang YY; Mehrotra S; Droz-Rosario R; Liu J; Bhaumik M; White E; Shen Z
    PLoS Genet; 2011 Sep; 7(9):e1002291. PubMed ID: 21966279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
    Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
    Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
    Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
    Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
    BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of BCCIP in chromosome stability and cytokinesis.
    Meng X; Fan J; Shen Z
    Oncogene; 2007 Sep; 26(43):6253-60. PubMed ID: 17452982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCCIP is required for the nuclear localization of the p21 protein.
    Fan J; Wray J; Meng X; Shen Z
    Cell Cycle; 2009 Sep; 8(18):3019-24. PubMed ID: 19713748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of G1 to S cell cycle progression by BCCIP beta.
    Meng X; Liu J; Shen Z
    Cell Cycle; 2004 Mar; 3(3):343-8. PubMed ID: 14726710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCCIP is required for nucleolar recruitment of eIF6 and 12S pre-rRNA production during 60S ribosome biogenesis.
    Ye C; Liu B; Lu H; Liu J; Rabson AB; Jacinto E; Pestov DG; Shen Z
    Nucleic Acids Res; 2020 Dec; 48(22):12817-12832. PubMed ID: 33245766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
    Morrison CD; Allington TM; Thompson CL; Gilmore HL; Chang JC; Keri RA; Schiemann WP
    Oncotarget; 2016 Nov; 7(45):72777-72794. PubMed ID: 27626309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.